
Adult Immunization
Latest News

AHA, ACC Issue First Clinical Guideline for CKM Syndrome

Retatrutide Phase 3 Data Show Weight, A1C Reductions in Obesity and Type 2 Diabetes

Semaglutide Boosts Quality of Life in T2D and CKD, FLOW Trial Analysis Finds

5 FDA Decisions for Primary Care to Know from May 2026

Pediatric Influenza Vaccination Linked to Fewer Diagnoses in Claims Study

Shorts










Latest Videos
All News

The FDA today issued a Complete Response Letter for Cingulate’s CTx-1301 for ADHD, citing CMC-related requests and no current safety or efficacy concerns.

FDA approved ensitrelvir for COVID-19 postexposure prophylaxis in adults and adolescents aged 12 years and older after exposure.

FDA approval expands Afrezza as an inhaled mealtime insulin option for pediatric patients with diabetes aged 6 years and older.

A national survey found high awareness of prenatal health guidance but gaps on alcohol avoidance, iron use, and gestational weight gain.

Post hoc phase 3 analyses linked centanafadine to improved executive function and emotional regulation in adults with ADHD.

ACS updated colorectal cancer screening guidance, reaffirming screening at age 45 and adding newer stool-based and blood-based options.

Kohli discusses the FDA approval of baxdrostat (Baxfendy), the first aldosterone synthase inhibitor for adults with uncontrolled hypertension.

A validated AI phenotyping tool identified chronic long COVID burden missed by ICD surveillance in nearly 460,000 COVID-19 patients.

Elunetirom received FDA Fast Track designation as an adjunctive therapy for bipolar depression, with phase 2 AMPLIFY-BD data expected in 2026.













































































































































































